#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dent's disease Adrenogenital syndrome Immunodeficiency congenital Thromboangiitis obliterans Dementia with Lewy bodies Prostate cancer Arteriovenous malformation Amyotrophic lateral sclerosis Subarachnoid haemorrhage Liver transplant rejection Chronic kidney disease Progressive multifocal leukoencephalopathy Selective polysaccharide antibody deficiency Vulval cancer B-cell type acute leukaemia More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Treatment Hyperoxaluria – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency Haemophilia B with anti factor IX – Treatment Haemophilia – Diagnostics Short-bowel syndrome – Basic Information Cholangitis sclerosing – Life with Disease Marginal zone lymphoma refractory – Diagnostics Primary hyperoxaluria – Diagnostics Ocular melanoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FERUMOXTRAN-10 Xanthum Gum Chlorpromazine Mbs2320 Rocatinlimab Verapamil Hydrochloride Eliglustat Tartrate Vrdn-001 Etrumadenant Bi 690517 Human Serum Albumin 5% Ociperlimab BENZYDAMINE HYDROCHLORIDE Cefazolin Sodium Natalizumab Asundexian Bidridistrogene Xeboparvovec Methylprednisolone Acetate Mebeverine Hydrochloride Alizapride More therapies…

    Learn about Your Condition

    Muscle hypertrophy Apathy Testicular germ cell cancer Neoplasm Large cell lung cancer Diabetic neuropathy Infertility Diabetic autonomic neuropathy Myeloid leukaemia Breast cancer recurrent Adrenocortical carcinoma Primary hyperthyroidism Klinefelter's syndrome Eosinophilic gastritis Choroidal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny W Bialymstoku

Uniwersytecki Szpital Kliniczny W Bialymstoku

Zurawia 14, Bialystok, 15-540, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Long-term Safety Study of Tadalafil and Macitentan for Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Macitentan
    • Selexipag
    • Tadalafil
    Bulgaria France Hungary Poland

  • Study on Colchicine for Preventing Artery Narrowing in Patients with Lower Extremity Artery Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colchicine
    Poland

  • Study on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cladribine
    • Cytarabine
    • Daunorubicin Hydrochloride
    Poland

  • Study Comparing Erdafitinib and Mitomycin for Patients with Intermediate-risk Non-muscle Invasive Bladder Cancer with FGFR Gene Alterations

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Erdafitinib
    • Gemcitabine Hydrochloride
    • Mitomycin
    Austria Belgium Czechia Denmark France Germany +4

  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated Drugs:
    • Finerenone
    Austria Bulgaria Croatia Czechia Germany Greece +9

  • Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer stage III
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • 2-Amino-9-((2R,4R,5R)-4-Hydroxy-5-(Hydroxymethyl) Tetrahydrofuran-2-Yl)-1,4,5,9-Tetrahydro-6H-Purine-6-Thione
    • Cemiplimab
    Bulgaria Hungary Poland Romania

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Chronic kidney disease
    • End stage renal disease
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Abelacimab
    Bulgaria Croatia Czechia Estonia Finland Germany +9

  • Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiac failure
    • Obesity
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17
Previous Page
1 … 4 5 6 7 8 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!